IP Library Granted Patent US 10,960,209
Granted Patent B2
US 10,960,209 · App. 16/320,288 · Granted Mar 30, 2021

Neuromodulation of adrenal gland

Inventors: Arun Sridhar (Stevenage, GB); Corey Smith (Cleveland, OH); Kyle Wolf (Cleveland, OH); Georgy Zarkua (Cleveland, OH); Shyue-An Chan (Cleveland, OH)
Assignees: Galvani Bioelectronics Limited; Case Western Reserve University
A61N1/36082A61N1/0556A61N1/36157A61N1/36171A61N1/36178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,960,209
App. No.
16/320,288
Granted
Mar 30, 2021
Kind
B2
Abstract

Modulation of neural signaling of a branch of the GSN supplying the adrenal gland can regulate the secretion of signaling molecules from the adrenal medulla. In particular, epinephrine, norepinephrine and enkephalin release can be independently regulated.

Claims (9)

1. A device or system for modulating the neural activity of a branch of the greater splanchnic nerve (GSN) between the suprarenal ganglion and the adrenal gland in a subject, the device or system comprising: at least one transducer suitable for placement on or around the whole branch of the GSN between the suprarenal ganglion and the adrenal gland or a division of the branch of the GSN between the suprarenal ganglion and the adrenal gland, and a signal generator for generating at least one signal to be applied to the branch of the GSN between the suprarenal ganglion and the adrenal gland via the at least one transducer such that the at least one signal inhibits the neural activity of the branch of the GSN between the suprarenal ganglion and the adrenal gland to produce a physiological response in the subject, wherein the physiological response is a decrease in the secretion of epinephrine (Epi), norepinephrine (NE), or enkephalin from the adrenal medulla, and wherein the at least one transducer is at least one electrode, and the signal generator is a voltage or current source configured to generate an electrical signal to be applied to the branch of the GSN between the suprarenal ganglion and the adrenal gland via the at least one electrode, and wherein the stimulation electrical signal has a frequency of between 1 Hz and 10 Hz.

2. The device or system of claim 1 , wherein the at least one transducer is at least one electrode, and the signal generator is a voltage or current source configured to generate an electrical signal to be applied to the branch of the GSN between the suprarenal ganglion and the adrenal gland, via the at least one electrode.

3. The device or system of claim 2 , wherein the signal generator is configured to generate an electrical inhibition signal adapted to inhibit neural activity in the branch of the GSN between the suprarenal ganglion and the adrenal gland.

4. The device or system of claim 3 , wherein the signal generator is configured to apply a first signal to the first transducer independently of the second transducer, wherein the first and/or second signal is an electrical inhibition signal adapted to inhibit neural activity in the branch of the GSN supplying the adrenal gland.

5. A method of reversibly modulating neural activity in a branch of the GSN supplying the adrenal gland, comprising: (i) implanting in the subject a device or system of claim 1 ; positioning the transducer in signaling signalling contact with the branch of the GSN between the suprarenal ganglion and the adrenal gland.

6. A device or system for modulating the neural activity of a branch of the greater splanchnic nerve (GSN) supplying the adrenal gland in a subject between the suprarenal ganglion and the adrenal gland in a subject, the device or system comprising: a first transducer suitable for placement on or around the anterior division of the branch of the GSN, a second transducer suitable for placement on or around the posterior division of the branch of the GSN, and a signal generator for generating at least one signal to be selectively applied to the GSN division(s) via the first and/or second transducers respectively such that the at least one signal inhibits the neural activity of the GSN division(s) to produce a physiological response in the subject, wherein the physiological response is a decrease in secretion of epinephrine (Epi), norepinephrine (NE) or enkephalin from the adrenal medulla.

7. The device or system of claim 6 , wherein the signal generator is configured to generate a first signal to be applied via the first transducer, and a second signal to be applied via the second transducer, wherein the first signal is different from the second signal.

8. The device or system of claim 6 , wherein the signal generator is configured to apply a first signal to the first transducer independently of the second transducer.

9. A method of treating a norepinephrine-related pathology, a epinephrine-related pathology, an enkephalin-related pathology, or a condition associated with impaired control of adrenal medullary secretion, such as impaired catecholamine and/or enkephalin control, comprising applying at least one signal to a branch of the greater splanchnic nerve (GSN) supplying the adrenal gland in a subject, preferably the branch of the GSN between the suprarenal ganglion and the adrenal gland, via at least one transducer that is suitable for placement on or around a GSN branch, such that the at least one signal inhibits the neural activity of the GSN branch to produce a physiological response in the subject, wherein the physiological response is a decrease in secretion of signaling molecules from the adrenal medulla, and wherein the at least one transducer is at least one electrode, and the signal is an electrical signal to be applied to the GSN branch via the at least one electrode, and wherein the stimulation electrical signal has a frequency of between 1 Hz and 10 Hz.

Assignments (4)
CHANGE OF ADDRESS Recorded Apr 16, 2025
From: GALVANI BIOELECTRONICS LIMITED
To: GALVANI BIOELECTRONICS LIMITED
Reel/Frame 070854/0393 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2021
From: SRIDHAR, ARUN
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 055326/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2021
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: GALVANI BIOELECTRONICS LIMITED
Reel/Frame 055326/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2021
From: SMITH, COREY; WOLF, KYLE; ZARKUA, GEORGY; CHAN, SHYUE-AN
To: CASE WESTERN RESERVE UNIVERSITY
Reel/Frame 055326/0239 →
Continuity (2)
Provisional Application 62366243 · Jul 25, 2016
Related Publication 20200179699A1 · Jun 11, 2020
Cited By (3)
US 12,408,974 US 12,478,806 US 12,539,167